Evidence map›Paper›PMID 40310339›Full record

ReviewClinics and practice2025

A Quantitative Systematic Review on the Analgesic Efficacy and Adverse Effects of Ketorolac in Third Molar Surgery.

Mario Alberto Isiordia-Espinoza, Othoniel Hugo Aragon-Martinez, Nicolás Addiel Serafín-Higuera, Sandra López-Verdín, Eduardo Gómez-Sánchez, Nelly Molina-Frechero, Ronell Bologna-Molina, Juan Manuel Guzmán-Flores, Itzel Joselyn Mora-Falcón

Abstract readReview
In one paragraph

Review in Clinics and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mario Alberto Isiordia-EspinozaDivisión de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos 47620, Mexico.ORCID 0000-0001-8389-6866
Othoniel Hugo Aragon-MartinezDepartamento de Farmacología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78290, Mexico.
Nicolás Addiel Serafín-HigueraFacultad de Odontología Mexicali, Universidad Autónoma de Baja California, Mexicali 21040, Mexico.ORCID 0000-0002-0402-3985
Sandra López-VerdínCentro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44100, Mexico.ORCID 0000-0002-8397-1720
Eduardo Gómez-SánchezCentro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44100, Mexico.ORCID 0000-0001-9603-7040
Nelly Molina-FrecheroDepartamento de Atención a la Salud, Universidad Autónoma Metropolitana-Unidad Xochimilco, Ciudad de México 14387, Mexico.ORCID 0000-0002-0435-053X
Ronell Bologna-MolinaÁrea de Patología Molecular, Facultad de Odontología, Universidad de la República de Uruguay, Montevideo 11200, Uruguay.ORCID 0000-0001-9755-4779
Juan Manuel Guzmán-FloresDivisión de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos 47620, Mexico.ORCID 0000-0002-4673-112X
Itzel Joselyn Mora-FalcónDivisión de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos 47620, Mexico.ORCID 0000-0001-7504-8453

Funding

Universidad de Guadalajara PROSNI 2024 by Dr. Mario Alberto Isiordia-Espinoza
6 · The paper itself

Abstract

objectivesThis study aimed to determine the number needed to treat (NNT) of ketorolac in comparison to placebo after third molar surgery.

methodsStudies located in PubMed, Scopus, and Web of Science were evaluated with the Cochrane Risk of Bias assessment tool. Data on the onset of analgesia, the number of patients requiring rescue medication, the global or general evaluation of the study medication, and adverse effects were extracted. Data analysis was performed using Review Manager 5.3 software for Windows.

resultsThe qualitative assessment of the included studies showed that ketorolac was more effective than a placebo and the quantitative evaluation on the onset of analgesia (NNT = 1.6 (95%CIs = 1.4, 1.9), n = 301), the number of patients who took rescue analgesics (NNT = 3.6 (95%CIs = 2.8 to 4.9), n = 563), and the global evaluation of the treatments (NNT = 1.7 (95%CIs = 1.5 to 1.9), n = 475) showed estimates of analgesic efficacy with a statistical difference in favor of ketorolac when compared with a placebo. No statistical difference was observed in adverse effects between ketorolac and placebo (n = 739).

conclusionsThere is scientific evidence of moderate quality that allows estimators of the analgesic efficacy of ketorolac to be calculated, which will significantly help the clinician who performs pharmacological treatment after third molar surgery.

Indexed as

ketorolacmeta-analysisplacebopostoperative dental painthird molar surgery

Identifiers

PMID40310339
PMCPMC12025813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.